Private raises · SEC Form D
Stipple Bio, Inc.: $65 million Raised, SEC Form D Filings
Company · Biotechnology · MA · incorporated 2021 · SEC CIK 1932776
Form D notices
A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.
| Filed | Type | Offering | Sold | Industry | |
|---|---|---|---|---|---|
| 6 Apr 2026 | New notice | $100 million | $65 million | Biotechnology | Form D |
Questions and answers
- How much has Stipple Bio, Inc. raised?
- Stipple Bio, Inc. reported $65 million sold in its largest Form D notice on file; its latest notice was filed on 6 April 2026. Form D amounts are what the issuer reported to the SEC.
- What is Stipple Bio, Inc.?
- Stipple Bio, Inc. is a company in biotechnology, based in Cambridge, Massachusetts, incorporated in 2021, according to its SEC Form D filings.
- How many Form D notices has Stipple Bio, Inc. filed?
- 1 notice between 6 April 2026 and 6 April 2026 in Tamarly's record, which starts on 1 October 2025.
Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "Stipple Bio, Inc.: SEC Form D filings", https://app.tamarly.ai/raisers/1932776, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.